BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 11251908)

  • 21. Tetanus antibodies measured by the toxin binding inhibition test (ToBI) in mothers and children in the Neonatal Tetanus Program in Vietnam.
    Anh NQ; Hong HA; Nhon TN; Thinh ND; Van NT; Hendriks J
    Dev Biol Stand; 1999; 101():247-53. PubMed ID: 10566798
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Titres of specific antibodies to poliovirus type 3 and tetanus toxoid in saliva and serum of children with recurrent upper respiratory tract infections.
    Cardinale F; Gentile V; Brunetti L; Hanson LA; Armenio L
    Pediatr Allergy Immunol; 2001 Feb; 12(1):42-8. PubMed ID: 11251864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific IgA subclass responses in serum and saliva: a 12-month follow-up study after parenteral booster immunization with tetanus toxoid.
    Engström PE; Gustafson R; Granberg M; Engström GN
    Acta Odontol Scand; 2002 Aug; 60(4):198-202. PubMed ID: 12222642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of vitamin A supplementation on immunoglobulin G subclass responses to tetanus toxoid in children.
    Semba RD; Muhilal ; Scott AL; Natadisastra G; West KP; Sommer A
    Clin Diagn Lab Immunol; 1994 Mar; 1(2):172-5. PubMed ID: 7496940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subnormal and waning immunity to tetanus toxoid in previously vaccinated HIV-infected children and response to booster doses of the vaccine.
    Choudhury SA; Matin F
    Int J Infect Dis; 2013 Dec; 17(12):e1249-51. PubMed ID: 24139228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum antibodies to diphtheria-tetanus-pertussis vaccine components in Argentine children.
    Pasetti M; Eriksson P; Ferrero F; Manghi M
    Infection; 1997; 25(6):339-45. PubMed ID: 9427051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isotype composition of antibodies to streptococcus group B type III polysaccharide and to tetanus toxoid in maternal, cord blood sera and in breast milk.
    Lagergård T; Thiringer K; Wassén L; Schneerson R; Trollfors B
    Eur J Pediatr; 1992 Feb; 151(2):98-102. PubMed ID: 1537371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
    Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
    Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgG and IgG subclass specific antibody responses to diphtheria and tetanus toxoids in newborns and infants given DTP immunization.
    Dengrove J; Lee EJ; Heiner DC; St Geme JW; Leake R; Baraff LJ; Ward JI
    Pediatr Res; 1986 Aug; 20(8):735-9. PubMed ID: 3737285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoglobulin G (IgG) subclass distribution and IgG1 avidity of antibodies in human immunodeficiency virus-infected individuals after revaccination with tetanus toxoid.
    Kroon FP; van Tol MJ; Jol-van der Zijde CM; van Furth R; van Dissel JT
    Clin Diagn Lab Immunol; 1999 May; 6(3):352-5. PubMed ID: 10225835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-administration of a novel Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine does not interfere with the immune response to antigens contained in infant vaccines routinely used in the United States.
    Marshall GS; Marchant CD; Blatter M; Friedland LR; Aris E; Miller JM
    Hum Vaccin; 2011 Feb; 7(2):258-64. PubMed ID: 21307655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK.
    Hazlewood M; Nusrat R; Kumararatne DS; Goodall M; Raykundalia C; Wang DG; Joyce HJ; Milford-Ward A; Forte M; Pahor A
    Clin Exp Immunol; 1993 Aug; 93(2):157-64. PubMed ID: 8348740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dot immunoassay for the simultaneous determination of postvaccination immunity against pertussis, diphtheria, and tetanus.
    Khramtsov P; Bochkova M; Timganova V; Zamorina S; Rayev M
    Anal Bioanal Chem; 2017 Jun; 409(15):3831-3842. PubMed ID: 28374129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity and reactogenicity of a Haemophilus influenzae type b tetanus conjugate vaccine when administered separately or mixed with concomitant diphtheria-tetanus-toxoid and acellular pertussis vaccine for primary and for booster immunizations.
    Schmitt HJ; Zepp F; Müschenborn S; Sümenicht G; Schuind A; Beutel K; Knuf M; Bock HL; Bogaerts H; Clemens R
    Eur J Pediatr; 1998 Mar; 157(3):208-14. PubMed ID: 9537487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody affinity and IgG subclass of responses to tetanus toxoid in patients with rheumatoid arthritis and systemic lupus erythematosus.
    Devey ME; Bleasdale K; Isenberg DA
    Clin Exp Immunol; 1987 Jun; 68(3):562-9. PubMed ID: 3652524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pertussis toxin enhanced IgG1 and IgE responses to primary tetanus immunization are mediated by interleukin-4 and persist during secondary responses to tetanus alone.
    Samore MH; Siber GR
    Vaccine; 1996 Mar; 14(4):290-7. PubMed ID: 8744555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diphtheria, tetanus and pertussis antibodies in 10-year-old children before and after a booster dose of three toxoids: implications for the timing of a booster dose.
    Trollfors B; Knutsson N; Taranger J; Mark A; Bergfors E; Sundh V; Lagergård T
    Eur J Pediatr; 2006 Jan; 165(1):14-8. PubMed ID: 16249929
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of in vitro Vero cell assay and ELISA in the United States potency test of vaccines containing adsorbed diphtheria and tetanus toxoids.
    Gupta RK; Siber GR
    Dev Biol Stand; 1996; 86():207-15. PubMed ID: 8785950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Higher Tetanus Toxoid Immunity 2 Years After PsA-TT Introduction in Mali.
    Basta NE; Borrow R; Berthe A; Onwuchekwa U; Dembélé AT; Almond R; Frankland S; Patel S; Wood D; Nascimento M; Manigart O; Trotter CL; Greenwood B; Sow SO
    Clin Infect Dis; 2015 Nov; 61 Suppl 5(Suppl 5):S578-85. PubMed ID: 26553691
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of transcutaneous immunization with co-administered antigen and cholera toxin on systemic and mucosal antibody responses in sheep.
    Chen D; Colditz IG; Glenn GM; Tsonis CG
    Vet Immunol Immunopathol; 2002 Jul; 86(3-4):177-82. PubMed ID: 12007883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.